The generic name for a synthetic pharmaceutical preparation that was the first effective drug against bacterial infection with pneumococci, gonococci, etc. It was developed in 1938 in Germany and Britain by the German scientist Gerhard Domagk (1895–1964). He received the 1939 Nobel Prize in Physiology or Medicine for his discovery. Many bacteria, unfortunately, soon became resistant.
Subjects: Public Health and Epidemiology.